Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
3Z Ehf has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single matter is assigned to 1 distinct examiner within 1 distinct art unit.
The busiest examiner for this portfolio is KOSTURKO, GEORGE W, who is responsible for the 1 pending office action. Because the entire portfolio consists of this single action, the prosecution strategy is entirely dependent on the interactions with this 1 examiner. The focus within a single art unit indicates a specific technical scope for the current filing.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOSTURKO, GEORGE W | 1 | 54.6% | +49.0% |
| PIHONAK, SARAH | 1 | 61.4% | +42.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19427233 | NOVEL TREATMENTS | KOSTURKO, GEORGE W | — |
| 18274945 | NOVEL TREATMENTS | PIHONAK, SARAH | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19427233 | NOVEL TREATMENTS | KOSTURKO, GEORGE W | 1621 | §102§103DP | Non-Final OA | — | Pending | Dec 19, 2025 |
| 18274945 | NOVEL TREATMENTS | PIHONAK, SARAH | 1627 | §103DP | Final Rejection | — | Pending | Jul 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial3Z Ehf has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
George W Kosturko has the most, with 1 of 3Z Ehf's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
